Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action - PubMed (original) (raw)

Review

. 2007 Jun;30(6):1335-43.

doi: 10.2337/dc07-0228. Epub 2007 Mar 2.

Affiliations

• PMID: 17337495
• DOI: 10.2337/dc07-0228

Review

Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action

Daniel J Drucker. Diabetes Care. 2007 Jun.

No abstract available

PubMed Disclaimer

Similar articles

• Dipeptidyl peptidase-4 inhibitors: clinical data and clinical implications.
  Ahrén B. Ahrén B. Diabetes Care. 2007 Jun;30(6):1344-50. doi: 10.2337/dc07-0233. Epub 2007 Mar 2. Diabetes Care. 2007. PMID: 17337494 Review. No abstract available.
• Dipeptidyl peptidase IV inhibitors and the incretin system in type 2 diabetes mellitus.
  Langley AK, Suffoletta TJ, Jennings HR. Langley AK, et al. Pharmacotherapy. 2007 Aug;27(8):1163-80. doi: 10.1592/phco.27.8.1163. Pharmacotherapy. 2007. PMID: 17655515 Review.
• [Sitagliptin. Dipeptidylpeptidase 4 inhibitor for patients with diabetes mellitus type 2].
  Musch A, Heinzl S. Musch A, et al. Med Monatsschr Pharm. 2007 Aug;30(8):282-6; quiz 287-8. Med Monatsschr Pharm. 2007. PMID: 17879807 Review. German. No abstract available.
• [Dipeptidylpeptidase IV inhibitors and dual action PPAR-agonists].
  Heinzl S. Heinzl S. Med Monatsschr Pharm. 2006 Mar;29(3):93-6. Med Monatsschr Pharm. 2006. PMID: 16550882 Review. German. No abstract available.
• Incretin mimetics vie for slice of type 2 diabetes market.
  Shaffer C. Shaffer C. Nat Biotechnol. 2007 Mar;25(3):263. doi: 10.1038/nbt0307-263. Epub 2007 Mar 1. Nat Biotechnol. 2007. PMID: 17344865 No abstract available.

Cited by

• A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation.
  Zhong J, Rao X, Deiuliis J, Braunstein Z, Narula V, Hazey J, Mikami D, Needleman B, Satoskar AR, Rajagopalan S. Zhong J, et al. Diabetes. 2013 Jan;62(1):149-57. doi: 10.2337/db12-0230. Epub 2012 Aug 30. Diabetes. 2013. PMID: 22936179 Free PMC article.
• Role of phosphodiesterase and adenylate cyclase isozymes in murine colonic glucagon-like peptide 1 secreting cells.
  Friedlander RS, Moss CE, Mace J, Parker HE, Tolhurst G, Habib AM, Wachten S, Cooper DM, Gribble FM, Reimann F. Friedlander RS, et al. Br J Pharmacol. 2011 May;163(2):261-71. doi: 10.1111/j.1476-5381.2010.01107.x. Br J Pharmacol. 2011. PMID: 21054345 Free PMC article.
• Association of DPP-4 activity with BMD, body composition, and incident hip fracture: the Cardiovascular Health Study.
  Carbone LD, Bůžková P, Fink HA, Robbins JA, Bethel M, Isales CM, Hill WD. Carbone LD, et al. Osteoporos Int. 2017 May;28(5):1631-1640. doi: 10.1007/s00198-017-3916-4. Epub 2017 Feb 2. Osteoporos Int. 2017. PMID: 28150034 Free PMC article.
• The Dietary Furocoumarin Imperatorin Increases Plasma GLP-1 Levels in Type 1-Like Diabetic Rats.
  Wang LY, Cheng KC, Li Y, Niu CS, Cheng JT, Niu HS. Wang LY, et al. Nutrients. 2017 Oct 30;9(11):1192. doi: 10.3390/nu9111192. Nutrients. 2017. PMID: 29084156 Free PMC article.
• A randomized, placebo-controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control.
  Kadowaki T, Seino Y, Kaku K, Okamoto T, Kameya M, Sato A, Hirano T, Oshima N, Gantz I, O'Neill EA, Engel SS; Omarigliptin Study 039 Group. Kadowaki T, et al. Diabetes Obes Metab. 2021 Jun;23(6):1242-1251. doi: 10.1111/dom.14331. Epub 2021 Feb 17. Diabetes Obes Metab. 2021. PMID: 33512755 Free PMC article. Clinical Trial.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal